Intelligent Bio Solutions Inc
INBS6.140USD
-0.850-12.16%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
55.86MMarket Cap
LossP/E TTM
More Details of Intelligent Bio Solutions Inc Company
Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.
Intelligent Bio Solutions Inc Info
Ticker SymbolINBS
Company nameIntelligent Bio Solutions Inc
IPO dateDec 23, 2020
CEOSimeonidis (Harry)
Number of employees16
Security typeOrdinary Share
Fiscal year-endDec 23
Address135 W 41St St,
CityNEW YORK
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code10036
Phone16467905756
Websitehttps://ibs.inc/
Ticker SymbolINBS
IPO dateDec 23, 2020
CEOSimeonidis (Harry)
Company Executives of Intelligent Bio Solutions Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United Kingdom
2.87M
93.96%
Rest of world
132.70K
4.35%
Australia
29.17K
0.96%
Americas
22.64K
0.74%
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Sat, Nov 15
Updated: Sat, Nov 15
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
Other
86.34%
Shareholders
Shareholders
Proportion
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
Other
86.34%
Shareholder Types
Shareholders
Proportion
Hedge Fund
11.51%
Investment Advisor
1.33%
Individual Investor
0.99%
Investment Advisor/Hedge Fund
0.61%
Research Firm
0.14%
Other
85.42%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
2023Q2
43
60.27K
19.45%
+30.17K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Alyeska Investment Group, L.P.
613.89K
6.76%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
15.48K
0.17%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
51.45K
0.57%
+2.44K
+4.98%
Jun 30, 2025
Sakiris (Spiro Kevin)
53.93K
0.59%
--
--
Sep 11, 2025
Simeonidis (Harry)
40.41K
0.45%
--
--
Sep 11, 2025
Goldman Sachs & Company, Inc.
12.83K
0.14%
+10.00
+0.08%
Jun 30, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Date
Type
Ratio
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
FAQs
Who are the top five shareholders of Intelligent Bio Solutions Inc?
The top five shareholders of Intelligent Bio Solutions Inc are:
Alyeska Investment Group, L.P. holds 613.89K shares, accounting for 6.76% of the total shares.
The Vanguard Group, Inc. holds 15.48K shares, accounting for 0.17% of the total shares.
Geode Capital Management, L.L.C. holds 51.45K shares, accounting for 0.57% of the total shares.
Sakiris (Spiro Kevin) holds 53.93K shares, accounting for 0.59% of the total shares.
Simeonidis (Harry) holds 40.41K shares, accounting for 0.45% of the total shares.
Alyeska Investment Group, L.P. holds 613.89K shares, accounting for 6.76% of the total shares.
The Vanguard Group, Inc. holds 15.48K shares, accounting for 0.17% of the total shares.
Geode Capital Management, L.L.C. holds 51.45K shares, accounting for 0.57% of the total shares.
Sakiris (Spiro Kevin) holds 53.93K shares, accounting for 0.59% of the total shares.
Simeonidis (Harry) holds 40.41K shares, accounting for 0.45% of the total shares.
What are the top three shareholder types of Intelligent Bio Solutions Inc?
The top three shareholder types of Intelligent Bio Solutions Inc are:
Alyeska Investment Group, L.P.
Adar1 Capital Management LLC
The Vanguard Group, Inc.
Alyeska Investment Group, L.P.
Adar1 Capital Management LLC
The Vanguard Group, Inc.
How many institutions hold shares of Intelligent Bio Solutions Inc (INBS)?
As of 2025Q3, 31 institutions hold shares of Intelligent Bio Solutions Inc, with a combined market value of approximately 799.23K, accounting for 8.80% of the total shares. Compared to 2025Q2, institutional shareholding has increased by -2.45%.
What is the biggest source of revenue for Intelligent Bio Solutions Inc?
In FY2025, the -- business generated the highest revenue for Intelligent Bio Solutions Inc, amounting to -- and accounting for --% of total revenue.
